Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Cyteir Therapeutics Inc (CYT)

Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Cyteir Therapeutics Inc. is a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer. Cyteir Therapeutics Inc. is based in LEXINGTON, Mass.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2011 Dec, 2010
Sales 0 0 0 3,073,100 2,748,300
Sales Growth unch unch -100.00% +11.82% -1.48%
Net Income -46,060 -42,130 -20,820 207,800 172,300
Net Income Growth -9.33% -102.35% -110.02% +20.60% +6,992.00%

Balance Sheet

(Values in U.S. Thousands) Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2011 Dec, 2010
Total Assets 153,230 195,390 13,740 3,536,700 3,673,900
Total Assets Growth -21.58% +1,322.05% -99.61% -3.73% +3.22%
Total Liabilities 6,950 8,100 61,770 1,843,400 1,937,000
Total Liabilities Growth -14.20% -86.89% -96.65% -4.83% -2.97%

Cash Flow

(Values in U.S. Thousands) Dec, 2022 Dec, 2021 Dec, 2020 Dec, 2011 Dec, 2010
Operating Cash Flow -42,530 -36,030 -18,540 211,800 278,800
Operating Cash Flow Growth -18.04% -94.34% -108.75% -24.03% -50.68%
Net Cash Flow -42,600 178,790 -17,960 32,500 121,600
Change in Net Cash Flow -123.83% +1,095.49% -155.26% -73.27% -41.09%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.